BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2023 7:09:14 AM | Browse: 100 | Download: 225
 |
Received |
|
2023-05-21 09:27 |
|
Peer-Review Started |
|
2023-05-21 09:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-10 04:27 |
|
Revised |
|
2023-07-20 03:34 |
|
Second Decision |
|
2023-08-09 02:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-08-09 08:29 |
|
Articles in Press |
|
2023-08-09 08:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-08-06 03:20 |
|
Typeset the Manuscript |
|
2023-08-21 12:20 |
|
Publish the Manuscript Online |
|
2023-08-25 07:09 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Huttakan Navadurong, Kessarin Thanapirom, Salisa Wejnaruemarn, Thaninee Prasoppokakorn, Roongruedee Chaiteerakij, Piyawat Komolmit and Sombat Treeprasertsuk |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sombat Treeprasertsuk, MD, PhD, Professor, Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, 1873 Rama 4 Road, Pathumwan District, Bangkok 10330, Thailand. battan5410@gmail.com |
| Key Words |
Albumin-bilirubin score; Compensated cirrhosis; Hepatic decompensation risk |
| Core Tip |
The albumin-bilirubin (ALBI) score has been successfully applied to the prediction of survival in patients with non-malignant liver diseases of various etiologies. This study demonstrated that the ALBI score can accurately identify decompensation risk at the 3-year follow-up in patients with compensated cirrhosis. The ALBI score is a simple and ready-to-use tool to help clinicians monitor and make appropriate treatment strategies in patients with compensated cirrhosis. |
| Publish Date |
2023-08-25 07:09 |
| Citation |
Navadurong H, Thanapirom K, Wejnaruemarn S, Prasoppokakorn T, Chaiteerakij R, Komolmit P, Treeprasertsuk S. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. World J Gastroenterol 2023; 29(32): 4873-4882 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i32/4873.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i32.4873 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
